BIO-TECHNE Corp

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $104.5m $76.1m $126.2m $96.1m $229.3m $140.4m $272.1m $285.3m $168.1m $73.4m
Net Income (Loss) Available to Common Stockholders, Basic $126.0m $96.0m $229.1m $140.3m $271.9m $285.2m $168.1m $73.4m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $139.6m $263.1m $285.4m $168.1m $73.4m
Net Income (Loss) Attributable to Noncontrolling Interest ($825k) ($9.0m) $179k
Depreciation, Depletion and Amortization $42.8m $60.0m $64.5m $78.2m $82.7m $87.7m $101.1m $107.2m $111.7m $109.9m
Depreciation $42.8m $60.0m $64.5m $78.2m $82.7m $87.7m $101.1m $107.2m $111.7m $34.6m
Amortization of Intangible Assets $44.4m $47.1m $58.7m $61.1m $64.9m $74.1m $77.5m $79.9m $76.0m
Deferred Income Tax Expense (Benefit) ($2.6m) ($3.4m) ($46.7m) ($14.0m) $13.6m ($28.0m) $7.1m ($29.8m) ($40.2m) ($51.2m)
Share-based Payment Arrangement, Noncash Expense $9.4m $14.6m $28.2m $32.3m $32.4m $49.0m $42.2m $39.2m $38.0m $40.8m
Payment, Tax Withholding, Share-based Payment Arrangement $23.5m $28.9m $21.9m $6.5m
Share-based Payment Arrangement, Expense $46.4m $41.2m $40.3m
Goodwill and Intangible Asset Impairment $18.7m
Goodwill, Impairment Loss $0 $0 $0 $0 $0
Impairment of Intangible Assets (Excluding Goodwill) $0
Impairment of Intangible Assets, Finite-lived $0 $73.3m
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $8.6m
Equity Method Investment, Realized Gain (Loss) on Disposal $1.1m $6.8m $938k
Income (Loss) from Equity Method Investments ($1.1m) ($6.8m) $938k
Income Tax Expense (Benefit) $43.0m $35.9m ($198k) $15.9m $47.2m $8.6m $38.3m $53.2m $17.6m $25.1m
Interest Expense Nonoperating $15.7m $8.5m
Other Nonoperating Income (Expense) ($1.6m) ($1.6m) ($447k) ($13.6m) $137.7m ($75.6m) $15.3m $47.5m ($8.6m) $831k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Inventories $6.6m $732k $13.3m $13.6m $14.9m $7.1m $32.0m $30.2m $14.2m $18.1m
Proceeds from Stock Options Exercised $5.5m $5.3m $19.2m $38.0m $71.0m $65.1m $77.2m $29.8m $60.9m $51.7m
Debt and Equity Securities, Realized Gain (Loss) $1.1m $300k ($938k)
Gain (Loss) on Investments $49.3m $283k
Gain (Loss) Related to Litigation Settlement ($3.5m)
Goodwill $430.9m $579.0m $597.9m $732.7m $728.3m $843.1m $822.1m $872.7m $972.7m $980.9m
Nonoperating Income (Expense) ($3.1m) ($8.6m) ($10.2m) ($34.7m) $119.1m ($89.1m) $4.8m $39.7m ($21.0m) ($3.8m)
Operating Expenses $186.1m $254.0m $296.0m $326.8m $325.8m $395.6m $459.9m $470.9m $563.0m $688.0m
Revenue from Contract with Customer, Including Assessed Tax $643.0m $714.0m $738.7m
Net Cash Provided by (Used in) Operating Activities $143.9m $143.4m $170.4m $181.6m $205.2m $352.2m $325.3m $254.4m $299.0m $287.6m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $16.9m $15.2m $20.9m $25.4m $51.7m $44.3m $44.9m $38.2m $62.9m $31.0m
Payments to Acquire Businesses, Net of Cash Acquired $91.4m $253.8m $67.9m $289.5m $0 $225.4m $101.2m $169.7m
Payments for (Proceeds from) Other Investing Activities $25k ($680k) $0 $0
Net Cash Provided by (Used in) Investing Activities ($107.6m) ($306.0m) ($38.7m) ($336.8m) $27.1m ($243.5m) ($96.9m) ($265.6m) ($203.0m) ($35.2m)
Cash flows from financing activities:
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $776k $6.1m $36.4m $21.6m $147.1m $66.4m $26.1m $35.2m
Payments for Repurchase of Common Stock $15.4m $50.1m $43.2m $160.9m $19.6m $80.0m $275.7m
Payments of Ordinary Dividends, Common Stock $47.6m $47.3m $48.0m $48.4m $48.9m $49.6m $50.2m $50.3m $50.4m $50.4m
Proceeds from (Payments for) Other Financing Activities ($4.0m) ($6.3m) ($3.9m) ($19.3m) $788k ($2.5m)
Net Cash Provided by (Used in) Financing Activities ($23.1m) $189.4m ($99.2m) $134.4m ($183.8m) ($62.6m) ($242.9m) $22.6m ($122.4m) ($253.9m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($3.5m) $495k ($2.1m) ($308k) $45.7m $52.5m ($26.5m) $8.0m ($28.8m) $10.4m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $7.5m $9.8m $21.5m $18.6m $13.6m $11.0m $8.4m $14.5m $19.0m
Income Taxes Paid, Net $42.9m $35.1m $36.8m $42.0m $21.0m $30.3m $88.4m $65.3m $74.4m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.